A detailed history of Fairscale Capital, LLC transactions in Organon & Co. stock. As of the latest transaction made, Fairscale Capital, LLC holds 46 shares of OGN stock, worth $726. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46
Previous 46 -0.0%
Holding current value
$726
Previous $957,000 8.05%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$17.45 - $21.96 $802 - $1,010
46 New
46 $957,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.02B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Fairscale Capital, LLC Portfolio

Follow Fairscale Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairscale Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairscale Capital, LLC with notifications on news.